P&G: The 70-Year Dividend King Just Got Cheaper — Time to Buy the Dip?

Quick Take

Procter & Gamble (PG) is getting a fresh wave of attention as a defensive haven, and for good reason. The stock is trading near its 52-week low, yielding a solid 3%, and just extended its dividend increase streak to 70 consecutive years. We see this as a classic 'buy the dip' setup for income-focused investors, especially with the S&P 500's recent run looking stretched.

The News Catalyst: Dividend King Status Takes Center Stage

A flurry of articles this week has highlighted P&G's elite status as a Dividend King — a company that has raised its dividend for over 50 straight years. P&G's streak now stands at 70 years, after the April hike brought the quarterly payout to $1.0885 (or $4.354 annually). That's a level of consistency that few companies can match.

This isn't just about bragging rights. In a market where the S&P 500 has already risen 13.3% this year following a 16.4% gain in 2025, investors are increasingly looking for stability. P&G, with its portfolio of everyday essentials like Tide, Pampers, and Crest, is the quintessential defensive play — people keep buying soap and diapers regardless of what the economy does.

One article even compared P&G to Coca-Cola, another Dividend King, noting both offer reliable income. But here's the key difference: while Coke's stock has rallied 24% this year (making its yield less attractive), P&G's stock is actually down 0.78% to $144.08 — near the bottom of its 52-week range of $137.62 - $167.25. That divergence is exactly what catches our eye.

Our Data: What the Numbers Say

Let's dig into the fundamentals. P&G's gross margin sits at a healthy 50.87%, showing the company still has strong pricing power despite inflation. The dividend yield of 2.98% is well above the S&P 500 average, and the payout is well-covered by earnings — a critical factor for sustainability.

Here's a quick snapshot of the key metrics:

• Dividend Yield: 2.98% (vs. 1.3% for the average consumer staples ETF)
• Payout Ratio: ~60% (comfortable, leaves room for future hikes)
• Gross Margin: 50.87% (industry-leading)
• Market Cap: $335 billion (mega-cap stability)
• 52-Week Range: $137.62 - $167.25 (currently near the low end)

When we compare P&G to its peers, it stands out. The iShares Consumer Staples ETF (IYK), which holds P&G as its top weight at 12.97%, has returned 8.9% over the past year, while the more narrowly focused Invesco Food & Beverage ETF (PBJ) is down 1.0%. That's a clear sign that P&G's diversified staples exposure is outperforming the broader food and beverage space.

Valuation: Is the Discount Real?

At $144.08, P&G is trading at roughly 23x forward earnings — that's a slight discount to its 5-year average of 24x. Given the company's consistent earnings growth and defensive nature, we think the stock deserves a premium, not a discount.

The market seems to be pricing in concerns about volume growth and input costs, but P&G has repeatedly shown it can navigate these challenges through pricing and cost-cutting. With the stock near the low end of its range, the risk/reward is skewed to the upside.

Technicals: A Potential Bounce Setup

The stock has been in a downtrend since early 2026, but the selling appears to be losing momentum. Volume is light (13.5K shares today vs. an average of 8.8M), which suggests the recent decline is more about lack of buyers than aggressive selling. The stock is also sitting just above its 52-week low of $137.62, which could act as strong support.

If the broader market pulls back, P&G could see a flight to safety, pushing the stock back toward its 50-day moving average. We'd watch for a close above $150 to confirm a short-term bottom.

The Bottom Line

P&G is a rare combination of stability, income, and value. With a 3% yield, 70 years of dividend growth, and a stock price near its lows, this is a compelling entry point for long-term investors. The bear case — that consumer spending slows and P&G's growth stagnates — is real, but the company's track record of navigating downturns makes us lean bullish. We see 10-15% upside over the next 12 months, plus that growing dividend. Buy the dip.